Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes

by Rune V. Overgaard, Christin L. Hertz, Steen H. Ingwersen, Andrea Navarria, Daniel J. Drucker
Published 2021-09-01